Mateusz Hasso-Agopsowicz

1.3k total citations · 1 hit paper
34 papers, 657 citations indexed

About

Mateusz Hasso-Agopsowicz is a scholar working on Epidemiology, Infectious Diseases and Applied Microbiology and Biotechnology. According to data from OpenAlex, Mateusz Hasso-Agopsowicz has authored 34 papers receiving a total of 657 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 14 papers in Infectious Diseases and 10 papers in Applied Microbiology and Biotechnology. Recurrent topics in Mateusz Hasso-Agopsowicz's work include Antibiotic Use and Resistance (10 papers), Viral gastroenteritis research and epidemiology (9 papers) and Virology and Viral Diseases (8 papers). Mateusz Hasso-Agopsowicz is often cited by papers focused on Antibiotic Use and Resistance (10 papers), Viral gastroenteritis research and epidemiology (9 papers) and Virology and Viral Diseases (8 papers). Mateusz Hasso-Agopsowicz collaborates with scholars based in Switzerland, United States and United Kingdom. Mateusz Hasso-Agopsowicz's co-authors include Isabel Frost, Hatim Sati, Gagandeep Kang, Peter Beyer, Pilar García-Vello, Christian Lienhardt, Valeria Gigante, Birgitte Giersing, Benjamin A. Lopman and William P. Hausdorff and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Mateusz Hasso-Agopsowicz

31 papers receiving 645 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

WHO global research priorities for antimicrobial resistance in human health

2024 68 citations Mateusz Hasso-Agopsowicz, Hatim Sati et al. The Lancet Microbe profile →

Peers

Countries citing papers authored by Mateusz Hasso-Agopsowicz

Since Specialization

Citations

This map shows the geographic impact of Mateusz Hasso-Agopsowicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mateusz Hasso-Agopsowicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mateusz Hasso-Agopsowicz more than expected).

Fields of papers citing papers by Mateusz Hasso-Agopsowicz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mateusz Hasso-Agopsowicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mateusz Hasso-Agopsowicz. The network helps show where Mateusz Hasso-Agopsowicz may publish in the future.

Co-authorship network of co-authors of Mateusz Hasso-Agopsowicz

This figure shows the co-authorship network connecting the top 25 collaborators of Mateusz Hasso-Agopsowicz. A scholar is included among the top collaborators of Mateusz Hasso-Agopsowicz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mateusz Hasso-Agopsowicz. Mateusz Hasso-Agopsowicz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Length of hospital stay and associated treatment costs for patients with susceptible and antibiotic-resistant Salmonella infections: a systematic review and meta-analysis 2025 ·BMJ Open ·(unknown), Isabel Frost, Nichola R. Naylor, (unknown), Yeon‐Hee Kim, (unknown), (unknown), (unknown), (unknown), Omar Salman, (unknown), (unknown), Mateusz Hasso-Agopsowicz, Kaja Abbas	2
2	Identification of potential vaccines for use with microarray patches in low- and middle-income countries: An assessment from the Vaccine Innovation Prioritisation Strategy Alliance 2025 ·Vaccine ·(unknown), Birgitte Giersing, Jean‐Pierre Amorij, Mercy Mvundura, Mateusz Hasso-Agopsowicz, (unknown), Kristen Earle, Courtney Jarrahian, (unknown), (unknown)	0
3	A Practical Guide to Full Value of Vaccine Assessments 2024 ·Vaccines ·Caroline Trotter, Birgitte Giersing, Ann Lindstrand, Naor Bar‐Zeev, Tania Cernuschi, (unknown), Martin Friede, Joachim Hombach, Maarten Jansen, Mateusz Hasso-Agopsowicz, (unknown), So Yoon Sim, (unknown), Karene Hoi Ting Yeung, Philipp Lambach	5
4	An Application of an Initial Full Value of Vaccine Assessment Methodology to Measles-Rubella MAPs for Use in Low- and Middle-Income Countries 2024 ·Vaccines ·(unknown), (unknown), Mercy Mvundura, (unknown), Christopher J. Gregory, (unknown), Mateusz Hasso-Agopsowicz, Han Fu, Mark Jit, Shan‐hui Hsu, (unknown), (unknown), Kristen Earle, (unknown), Birgitte Giersing, Courtney Jarrahian, (unknown), Stefano Malvolti, Jean‐Pierre Amorij	4
5	Exploring Important Attributes, the Potential Use Cases and Feasibility of Introduction of Measles and Rubella Microarray Patches (MR-MAPs): Insights from Nine Countries 2024 ·Vaccines ·Mateusz Hasso-Agopsowicz, (unknown), Maarten Jansen, Balcha Masresha, (unknown), (unknown), (unknown), (unknown), Annet Kisakye, Anna-Léa Kahn, Birgitte Giersing	2
6	Measles–Rubella Microarray Patches Phase III Clinical Trial Framework: Proposal and Considerations 2024 ·Vaccines ·Darin Zehrung, Bruce L. Innis, Auliya A. Suwantika, Mahmoud Ameri, Robin Biellik, James C. Birchall, Alejandro Cravioto, Courtney Jarrahian, Lee Fairlie, James L. Goodson, Sonali Kochhar, Katrina Kretsinger, Chris Morgan, Mercy Mvundura, (unknown), (unknown), (unknown), (unknown), Birgitte Giersing, Mateusz Hasso-Agopsowicz	1
7	Identifying WHO global priority endemic pathogens for vaccine research and development (R&D) using multi-criteria decision analysis (MCDA): an objective of the Immunization Agenda 2030 2024 ·EBioMedicine ·Mateusz Hasso-Agopsowicz, (unknown), (unknown), (unknown), Ruth A. Karron, R. Prabhakar Rao, Kwaku Poku Asante, Meru Sheel, Erin Sparrow, Birgitte Giersing	13
8	A review of potential use cases for measles-rubella, measles-mumps-rubella, and typhoid-conjugate vaccines presented on microarray patches 2024 ·Vaccine ·(unknown), (unknown), (unknown), Stefano Malvolti, Mateusz Hasso-Agopsowicz, Birgitte Giersing, Jean‐Pierre Amorij, Courtney Jarrahian, (unknown), (unknown), (unknown)	4
9	Global and regional burden of attributable and associated bacterial antimicrobial resistance avertable by vaccination: modelling study 2023 ·BMJ Global Health ·(unknown), Marianne Holm, Isabel Frost, Mateusz Hasso-Agopsowicz, Kaja Abbas	34
10	Global and Regional Burden of Attributable and Associated Bacterial Antimicrobial Resistance Avertable by Vaccination: Modelling Study 2023 ·SSRN Electronic Journal ·Marianne Holm, Kaja Abbas, (unknown), Isabel Frost, Mateusz Hasso-Agopsowicz	1
11	Estimating the future global dose demand for measles–rubella microarray patches 2023 ·Frontiers in Public Health ·(unknown), Stefano Malvolti, (unknown), Carsten Mantel, Robin Biellik, Courtney Jarrahian, (unknown), Jean‐Pierre Amorij, (unknown), Mark Papania, Martin I. Meltzer, Balcha Masresha, (unknown), David N Dürrheim, Birgitte Giersing, Mateusz Hasso-Agopsowicz	9
12	Exploring potential applications of measles and rubella microarray patches (MR-MAPs): use case identification 2023 ·Frontiers in Public Health ·Stefano Malvolti, (unknown), (unknown), Carsten Mantel, Courtney Jarrahian, Jean‐Pierre Amorij, Birgitte Giersing, Mateusz Hasso-Agopsowicz	9
13	The role of bacterial vaccines in the fight against antimicrobial resistance: an analysis of the preclinical and clinical development pipeline 2022 ·The Lancet Microbe ·Isabel Frost, Hatim Sati, Pilar García-Vello, Mateusz Hasso-Agopsowicz, Christian Lienhardt, Valeria Gigante, Peter Beyer	105
14	Accelerating the Development of Measles and Rubella Microarray Patches to Eliminate Measles and Rubella: Recent Progress, Remaining Challenges 2022 ·Frontiers in Public Health ·Mateusz Hasso-Agopsowicz, Natasha S. Crowcroft, Robin Biellik, Christopher J. Gregory, (unknown), Jean‐Pierre Amorij, (unknown), Kristen Earle, (unknown), Courtney Jarrahian, Mercy Mvundura, (unknown), David N Dürrheim, Birgitte Giersing	20
15	Global diarrhoea-associated mortality estimates and models in children: Recommendations for dataset and study selection 2021 ·Vaccine ·(unknown), H Prudden, Mark Jit, Peter G. Smith, Gagandeep Kang, Mark S. Riddle, Benjamin A. Lopman, Virginia E. Pitzer, Claudio F. Lanata, James A Platts-Mills, Robert F. Breiman, Birgitte Giersing, Mateusz Hasso-Agopsowicz	14
16	World Health Organization Expert Working Group: Recommendations for assessing morbidity associated with enteric pathogens 2021 ·Vaccine ·Mateusz Hasso-Agopsowicz, Benjamin A. Lopman, Claudio F. Lanata, Elizabeth T. Rogawski McQuade, Gagandeep Kang, H Prudden, Fakher Rahim, James A Platts-Mills, Karen L. Kotloff, Mark Jit, Mark S. Riddle, Patricia B. Pavlinac, Paula M. Luz, Virginia E. Pitzer, Robert F. Breiman, Birgitte Giersing	20
17	Meeting Report: WHO Workshop on modelling global mortality and aetiology estimates of enteric pathogens in children under five. Cape Town, 28–29th November 2018 2020 ·Vaccine ·H Prudden, Mateusz Hasso-Agopsowicz, Robert E. Black, Christopher Troeger, Robert C. Reiner, Robert F. Breiman, Mark Jit, Gagandeep Kang, L Lamberti, Claudio F. Lanata, Benjamin A. Lopman, Wilfred Ndifon, Virginia E. Pitzer, James A Platts-Mills, Mark S. Riddle, Peter G. Smith, Raymond Hutubessy, Birgitte Giersing	15
18	Maternal Latent Mycobacterium tuberculosis Does Not Affect the Infant Immune Response Following BCG at Birth: An Observational Longitudinal Study in Uganda 2020 ·Frontiers in Immunology ·Lawrence Lubyayi, Patrice A. Mawa, (unknown), (unknown), (unknown), (unknown), (unknown), Hellen Akurut, Josephine Tumusiime, Mateusz Hasso-Agopsowicz, Pontiano Kaleebu, Jonathan Levin, Hazel M. Dockrell, Steven G. Smith, Emily L. Webb, Alison M. Elliott, Stephen Cose	7
19	Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules 2019 ·The Lancet Global Health ·Andrew Clark, Jacqueline E. Tate, Umesh D. Parashar, Mark Jit, Mateusz Hasso-Agopsowicz, Nicholas Henschke, Benjamin A. Lopman, Kevin van Zandvoort, Clint Pecenka, Paul Fine, Colin Sanderson	41
20	Differential DNA methylation of potassium channel KCa3.1 and immune signalling pathways is associated with infant immune responses following BCG vaccination 2018 ·Scientific Reports ·Mateusz Hasso-Agopsowicz, Thomas J. Scriba, Willem A. Hanekom, Hazel M. Dockrell, Steven G. Smith	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact